Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduction of PRA (Panel Reactive Antibody) in Sensitized Patients Awaiting Live-Donor Renal Transplantation

NCT00784979 is registered in ClinicalTrials.gov with Tampa General Hospital as lead sponsor.

NCT NCT00784979
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00784979 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduction of PRA (Panel Reactive Antibody) in Sensitized Patients Awaiting Live-Donor Renal Transplantation
Lead sponsor
Tampa General Hospital
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2002
Completion date
April 30, 2012
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease